Quick Answer
Dare Bioscience, Inc. reported Research And Development Expense of $5.52 million for the year ending 2025.
- Dare Bioscience, Inc. showed a decrease of -61.4% in Research And Development Expense from 2024 to 2025.
- This data is from Dare Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $3.48 million | Q2 2013: $3.20 million | Q3 2013: $1.59 million | Q4 2013: $1.44 million | Q1 2014: $1.50 million | Q2 2014: $2.65 million | Q3 2014: $2.93 million | Q4 2014: $4.70 million | Q1 2015: $5.02 million | Q2 2015: $6.68 million | Q3 2015: $7.09 million | Q4 2015: $7.16 million | Q1 2016: $9.77 million | Q2 2016: $7.52 million | Q3 2016: $7.09 million | Q4 2016: $3.18 million | Q1 2017: $27.8 thousand | Q2 2017: $3.6 thousand | Q3 2017: $280.8 thousand | Q1 2018: $1.09 million | Q2 2018: $2.22 million | Q3 2018: $1.45 million | Q1 2019: $1.69 million | Q2 2019: $2.51 million | Q3 2019: $1.97 million | Q1 2020: $2.38 million | Q2 2020: $5.55 million | Q3 2020: $6.20 million | Q1 2021: $5.73 million | Q2 2021: $7.34 million | Q3 2021: $10.43 million | Q1 2022: $5.81 million | Q2 2022: $6.80 million | Q3 2022: $4.46 million | Q1 2023: $5.02 million | Q2 2023: $6.04 million | Q3 2023: $6.67 million | Q1 2024: $3.35 million | Q2 2024: $4.93 million | Q3 2024: $2.68 million | Q1 2025: $2.30 million | Q2 2025: $1.43 million | Q3 2025: $1.18 million.
- Over the full 14 years of available data (2012 to 2025), Dare Bioscience, Inc.'s Research And Development Expense has declined by 65.1%.
- Historical annual values: Fiscal year 2025: $5.52 million | Fiscal year 2024: $14.31 million | Fiscal year 2023: $21.54 million | Fiscal year 2022: $30.04 million | Fiscal year 2021: $30.62 million | Fiscal year 2020: $20.77 million | Fiscal year 2019: $8.55 million | Fiscal year 2018: $6.41 million | Fiscal year 2017: $984.7 thousand | Fiscal year 2016: $72.7 thousand | Fiscal year 2015: $25.95 million | Fiscal year 2014: $11.77 million | Fiscal year 2013: $9.70 million | Fiscal year 2012: $15.81 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: